Patient-reported visual symptoms and spectacle independence following the implantation of a novel full visual range IOL.
CLOSE
MENU

Patient-reported visual symptoms and spectacle independence following the implantation of a novel full visual range IOL.


Content provided by Bausch + Lomb Medical Affairs.

Patient-reported visual symptoms and spectacle independence following the implantation of a novel full visual range IOL.


Content provided by Bausch + Lomb Medical Affairs.

Summary

PURPOSE: To evaluate the spectacle independence and frequency of visual symptoms following bilateral implantation of a full visual range (FVR) IOL.

METHODS: This retrospective chart review included 78 patients who underwent cataract surgery and implantation of an FVR IOL (enVista Envy, Bausch & Lomb). This IOL is designed to provide a continuous range of vision, enhancing both near and distance vision. Outcome measures were subjective assessment of spectacle independence and incidence of visual symptoms using the patient-reported spectacle independence (PRSIQ).

RESULTS: The percentage of patients who responded that they wore glasses or contacts 'none' or 'a little of the time' was 100% for distance and intermediate, and 92.9% for near vision. The proportion of patients who reported that they could function comfortably 'all or most of the time' without wearing glasses or contacts was 100% for distance, 96.4% for intermediate, and 89.2% for near vision. The proportion of patients who reported visual symptoms 'some', 'a little', or 'none of the time' was 89.3% for glare, 82.1% for halos, and 92.9% for starbursts.

CONCLUSION: The FVR IOL demonstrated excellent spectacle independence for distance, intermediate, and near vision. The minimal occurrence of visual disturbances contributed to good IOL performance and high levels of overall patient satisfaction.

For More Information:

Get Support

Contact Us

Contact a
Representative

Find My Local Rep link-out icon

Submit a
Medical Inquiry

Complete the Form